PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.304
https://www.valueinhealthjournal.com/article/S1098-3015(12)02017-7/fulltext
Title :
PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02017-7&doi=10.1016/j.jval.2012.08.304
First page :
A654
Section Title :
Cancer
Open access? :
No
Section Order :
1848